|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:drug
|
|
gptkbp:affiliatedWith
|
Ether
anticholinergic
skeletal muscle relaxant
|
|
gptkbp:ATCCode
|
M03BC01
|
|
gptkbp:CASNumber
|
83-98-7
|
|
gptkbp:contraindication
|
gptkb:myasthenia_gravis
glaucoma
urinary retention
|
|
gptkbp:discoveredBy
|
gptkb:George_Rieveschl
|
|
gptkbp:discoveredIn
|
1947
|
|
gptkbp:eliminationHalfLife
|
14 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:hasMolecularFormula
|
C18H23NO
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
orphenadrine
|
|
gptkbp:IUPACName
|
(RS)-2-(o-methoxyphenyl)-2-(methylamino)cyclohexan-1-one
|
|
gptkbp:KEGGID
|
D08313
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
NMDA receptor antagonist
anticholinergic
|
|
gptkbp:meltingPoint
|
98°C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
4476
4637
CHEMBL1201272
DB01173
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
intravenous
|
|
gptkbp:sideEffect
|
nausea
dizziness
drowsiness
dry mouth
urinary retention
|
|
gptkbp:synonym
|
gptkb:Disipal
gptkb:Norflex
|
|
gptkbp:UNII
|
A6XZA4FBCX
|
|
gptkbp:usedFor
|
pain relief
muscle spasm
|
|
gptkbp:bfsParent
|
gptkb:Muscle_Relaxants,_Central
|
|
gptkbp:bfsLayer
|
7
|